| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Vaccine immunogenetics: bedside to bench to population.
|
Vaccine
|
2008
|
2.01
|
|
2
|
Influenza virus resistance to antiviral agents: a plea for rational use.
|
Clin Infect Dis
|
2009
|
1.64
|
|
3
|
Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results.
|
Vaccine
|
2008
|
1.60
|
|
4
|
Personalized vaccines: the emerging field of vaccinomics.
|
Expert Opin Biol Ther
|
2008
|
1.59
|
|
5
|
Assessing participation bias in a population-based study of measles-mumps-rubella vaccine immunity in children and adolescents aged 12-18.
|
Paediatr Perinat Epidemiol
|
2007
|
1.45
|
|
6
|
Independence of measles-specific humoral and cellular immune responses to vaccination.
|
Hum Immunol
|
2012
|
1.44
|
|
7
|
Gender effects on humoral immune responses to smallpox vaccine.
|
Vaccine
|
2009
|
1.39
|
|
8
|
Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes.
|
J Infect Dis
|
2006
|
1.35
|
|
9
|
Application of pharmacogenomics to vaccines.
|
Pharmacogenomics
|
2009
|
1.30
|
|
10
|
2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine.
|
Hum Immunol
|
2010
|
1.30
|
|
11
|
Immunogenetics of seasonal influenza vaccine response.
|
Vaccine
|
2008
|
1.25
|
|
12
|
Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination.
|
Vaccine
|
2011
|
1.24
|
|
13
|
Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors.
|
J Allergy Clin Immunol
|
2007
|
1.24
|
|
14
|
Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.
|
Clin Vaccine Immunol
|
2008
|
1.21
|
|
15
|
Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.
|
OMICS
|
2011
|
1.21
|
|
16
|
A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine.
|
Vaccine
|
2011
|
1.18
|
|
17
|
Systems biology approaches to new vaccine development.
|
Curr Opin Immunol
|
2011
|
1.17
|
|
18
|
Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients.
|
Hum Genet
|
2012
|
1.15
|
|
19
|
SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine.
|
Immunogenetics
|
2010
|
1.15
|
|
20
|
Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.
|
Vaccine
|
2011
|
1.12
|
|
21
|
Adversomics: the emerging field of vaccine adverse event immunogenetics.
|
Pediatr Infect Dis J
|
2009
|
1.11
|
|
22
|
Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.
|
Semin Immunol
|
2013
|
1.11
|
|
23
|
Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?
|
PLoS Pathog
|
2011
|
1.10
|
|
24
|
The immunology of smallpox vaccines.
|
Curr Opin Immunol
|
2009
|
1.10
|
|
25
|
Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination.
|
J Immunol Methods
|
2008
|
1.09
|
|
26
|
Common SNPs/haplotypes in IL18R1 and IL18 genes are associated with variations in humoral immunity to smallpox vaccination in Caucasians and African Americans.
|
J Infect Dis
|
2011
|
1.09
|
|
27
|
The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.
|
Expert Rev Vaccines
|
2013
|
1.08
|
|
28
|
Genome-wide genetic associations with IFNγ response to smallpox vaccine.
|
Hum Genet
|
2012
|
1.08
|
|
29
|
Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees.
|
Cytokine
|
2010
|
1.06
|
|
30
|
Detection of measles virus-specific interferon-gamma-secreting T-cells by ELISPOT.
|
Methods Mol Biol
|
2005
|
1.05
|
|
31
|
Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA.
|
J Immunol Methods
|
2004
|
1.03
|
|
32
|
Studies of twins in vaccinology.
|
Vaccine
|
2007
|
1.02
|
|
33
|
Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics.
|
Vaccine
|
2009
|
1.02
|
|
34
|
Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach.
|
Expert Rev Vaccines
|
2012
|
1.01
|
|
35
|
Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine.
|
Hum Immunol
|
2005
|
1.00
|
|
36
|
Associations between SNPs in candidate immune-relevant genes and rubella antibody levels: a multigenic assessment.
|
BMC Immunol
|
2010
|
1.00
|
|
37
|
Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus.
|
J Am Soc Mass Spectrom
|
2005
|
1.00
|
|
38
|
Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine.
|
J Infect Dis
|
2002
|
0.98
|
|
39
|
Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development.
|
Vaccine
|
2009
|
0.96
|
|
40
|
Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination.
|
PLoS One
|
2013
|
0.95
|
|
41
|
Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination.
|
Viral Immunol
|
2012
|
0.94
|
|
42
|
Granzyme B ELISPOT assay to measure influenza-specific cellular immunity.
|
J Immunol Methods
|
2013
|
0.92
|
|
43
|
Differential cellular immune responses to wild-type and attenuated edmonston tag measles virus strains are primarily defined by the viral phosphoprotein gene.
|
J Med Virol
|
2010
|
0.92
|
|
44
|
Correlations between vaccinia-specific immune responses within a cohort of armed forces members.
|
Viral Immunol
|
2011
|
0.89
|
|
45
|
Human leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: persistence, dampening, and extinction of associations found after a first dose.
|
Vaccine
|
2011
|
0.89
|
|
46
|
High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination.
|
J Infect Dis
|
2012
|
0.88
|
|
47
|
Effect of human leukocyte antigen homozygosity on rubella vaccine-induced humoral and cell-mediated immune responses.
|
Hum Immunol
|
2009
|
0.88
|
|
48
|
Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals.
|
Hum Immunol
|
2013
|
0.88
|
|
49
|
Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children.
|
Clin Immunol
|
2005
|
0.88
|
|
50
|
Detection of vaccinia virus-specific IFNγ and IL-10 secretion from human PBMCs and CD8⁺ T cells by ELISPOT.
|
Methods Mol Biol
|
2012
|
0.88
|
|
51
|
A qualitative and quantitative comparison of two rubella virus-specific IgG antibody immunoassays.
|
Viral Immunol
|
2010
|
0.87
|
|
52
|
Identification of class II HLA-DRB1*03-bound measles virus peptides by 2D-liquid chromatography tandem mass spectrometry.
|
J Proteome Res
|
2005
|
0.87
|
|
53
|
Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes.
|
Vaccine
|
2012
|
0.86
|
|
54
|
Genetic basis for variation of vaccine response: our studies with rubella vaccine.
|
Paediatr Child Health
|
2009
|
0.86
|
|
55
|
Identification of Th0 cells responding to measles virus.
|
Hum Immunol
|
2005
|
0.84
|
|
56
|
Profiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titers.
|
Hum Vaccin Immunother
|
2015
|
0.83
|
|
57
|
Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts.
|
Immunol Res
|
2014
|
0.83
|
|
58
|
Detection of influenza A/H1N1-specific human IgG-secreting B cells in older adults by ELISPOT assay.
|
Viral Immunol
|
2014
|
0.83
|
|
59
|
Immune activation at effector and gene expression levels after measles vaccination in healthy individuals: a pilot study.
|
Hum Immunol
|
2006
|
0.81
|
|
60
|
Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination.
|
Hum Genet
|
2014
|
0.81
|
|
61
|
Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients.
|
Immunogenetics
|
2014
|
0.80
|
|
62
|
Replication of associations between cytokine and cytokine receptor single nucleotide polymorphisms and measles-specific adaptive immunophenotypic extremes.
|
Hum Immunol
|
2012
|
0.79
|
|
63
|
Associations between measles antibody levels and the protein structure of class II human leukocyte antigens.
|
Hum Immunol
|
2003
|
0.78
|
|
64
|
Cytokine production associated with smallpox vaccine responses.
|
Immunotherapy
|
2014
|
0.78
|
|
65
|
Adversomics: a new paradigm for vaccine safety and design.
|
Expert Rev Vaccines
|
2015
|
0.76
|
|
66
|
Testing vaccines in pediatric research subjects.
|
Vaccine
|
2009
|
0.76
|
|
67
|
Response surface methodology to determine optimal measles-specific cytokine responses in human peripheral blood mononuclear cells.
|
J Immunol Methods
|
2012
|
0.76
|
|
68
|
The personal touch: strategies toward personalized vaccines and predicting immune responses to them.
|
Expert Rev Vaccines
|
2014
|
0.75
|
|
69
|
Latex allergens are not detectable in reconstituted smallpox vaccine or vaccine vial stoppers.
|
J Allergy Clin Immunol
|
2004
|
0.75
|